Susanna Del Signore

Also affiliated with Blue Ventures, Bluebird Bio (France)

MedicineEconomics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Characterizing sarcopenia and sarcopenic obesity in patients aged 65 years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS)”.

Characterizing sarcopenia and sarcopenic obesity in patients aged 65 years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS)

BMC Geriatrics(2025)10.1186/s12877-025-05895-9

N/A

0.232DataRank · unranked

3 citations

Yves Rolland, Olivier Bruyère, Moı̈se Desvarieux, Lorenzo M. Donini, Raffaele Antonelli Incalzi +12 more

BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double‐Blind Randomised Interventional Phase 2b Trial

Journal of Cachexia Sarcopenia and Muscle(2025)10.1002/jcsm.13750

N/A

0DataRank · unranked

11 citations

Michael Dao, Kevin Cannon, Moı̈se Desvarieux, Sam S. Miller, Michael Paul Gimness +24 more